131 related articles for article (PubMed ID: 37846568)
1. Treatment approaches for severe Stenotrophomonas maltophilia infections.
Mojica MF; Bonomo RA; van Duin D
Curr Opin Infect Dis; 2023 Dec; 36(6):572-584. PubMed ID: 37846568
[TBL] [Abstract][Full Text] [Related]
2. Looking for
Ranieri EM; Denicolò S; Stolfa S; Dalfino L; Bavaro DF; Saracino A; Ronga L; Del Prete R; Mosca A
J Chemother; 2023 Nov; 35(7):610-613. PubMed ID: 37615040
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
4. Synergistic combination of aztreonam and ceftazidime/avibactam against resistant Stenotrophomonas maltophilia on pancreatitis.
De Almeida Torres N; Morales Junior R; Bueno Lopes LF; Zeigler R; Everson Uip D
J Infect Dev Ctries; 2023 Jun; 17(6):881-885. PubMed ID: 37406060
[TBL] [Abstract][Full Text] [Related]
5.
Crémet L; Joffraud L; Eschapasse E; Bihouée T; Tissot A; Gibaud S; Persyn E
Microb Drug Resist; 2022 Aug; 28(8):877-881. PubMed ID: 35763306
[TBL] [Abstract][Full Text] [Related]
6. Steno-sphere: Navigating the enigmatic world of emerging multidrug-resistant Stenotrophomonas maltophilia.
Kunz Coyne AJ; Herbin S; Caniff K; Rybak MJ
Pharmacotherapy; 2023 Aug; 43(8):833-846. PubMed ID: 37199104
[TBL] [Abstract][Full Text] [Related]
7. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
[TBL] [Abstract][Full Text] [Related]
8. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
Wei C; Ni W; Cai X; Cui J
Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
[TBL] [Abstract][Full Text] [Related]
9. Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro.
Lin Q; Zou H; Chen X; Wu M; Ma D; Yu H; Niu S; Huang S
BMC Microbiol; 2021 Feb; 21(1):60. PubMed ID: 33618662
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial
Hevia EC; Wooten L; Carr AL
Ann Pharmacother; 2024 Jul; 58(7):698-704. PubMed ID: 37776160
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
Lee YL; Liu CE; Ko WC; Hsueh PR
Int J Antimicrob Agents; 2023 Aug; 62(2):106878. PubMed ID: 37285926
[TBL] [Abstract][Full Text] [Related]
12. Optimizing Antibiotic Therapy for
Barrasa H; Morán MA; Fernández-Ciriza L; Isla A; Solinís MÁ; Canut-Blasco A; Rodríguez-Gascón A
Antibiotics (Basel); 2024 Jun; 13(6):. PubMed ID: 38927219
[No Abstract] [Full Text] [Related]
13. Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Araoka H; Baba M; Okada C; Abe M; Kimura M; Yoneyama A
Int J Infect Dis; 2017 May; 58():18-21. PubMed ID: 28257816
[TBL] [Abstract][Full Text] [Related]
14.
Su BA; Chen CC; Chen HJ; Lai HY; Tsai CH; Lai CC; Tang HJ; Chao CM
Front Microbiol; 2023; 14():1186669. PubMed ID: 37408643
[TBL] [Abstract][Full Text] [Related]
15. Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis.
Lee YL; Hsueh PR
Curr Opin Infect Dis; 2023 Dec; 36(6):481-494. PubMed ID: 37548375
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
Juhász E; Pongrácz J; Iván M; Kristóf K
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
[TBL] [Abstract][Full Text] [Related]
17. Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Lamm D; Meyer K; Vialichka A; Jurkovic M; Patel S; Mendes RE; Bulman ZP; Wenzler E
Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928733
[TBL] [Abstract][Full Text] [Related]
18. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
[No Abstract] [Full Text] [Related]
19. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
[TBL] [Abstract][Full Text] [Related]
20. Effect of antimicrobials on
Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
